Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations and Comprehensive Loss

v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
General and administrative $ 12,876,175 $ 7,051,468
Research and development 7,981,120 7,198,494
Loss from operations (20,857,295) (14,249,962)
Other income (expense):    
Change in fair value of warrant liabilities 115,301 (77,806)
Realized foreign currency translation loss from dissolution of subsidiaries (7,171)
Foreign currency gain 30,376
Other income 380,532
Change in fair value of derivative warrant liability (416,619)
Interest and dividends, net 327,193 423,184
Other income, net 429,612 345,378
Loss before income taxes (20,427,683) (13,904,584)
Provision for income taxes
Net loss $ (20,427,683) $ (13,904,584)
Weighted-average common shares outstanding, basic (in Shares) 7,031,050 1,096,082
Weighted-average common shares outstanding, diluted (in Shares) 7,031,050 1,096,082
Basic loss per share (in Dollars per share) $ (2.91) $ (12.69)
Diluted loss per share (in Dollars per share) $ (2.91) $ (12.69)
Comprehensive loss:    
Net loss $ (20,427,683) $ (13,904,584)
Foreign currency translation 18,766 (2,519)
Comprehensive loss $ (20,408,917) $ (13,907,103)